US Patent Issued to NKMAX on Aug. 5 for "Method of diagnosing cancer and diagnosis kit using measurement of NK cell activity" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,379,384, issued on Aug. 5, was assigned to NKMAX Co. LTD. (Gyeong-Gi-Do, South Korea).

"Method of diagnosing cancer and diagnosis kit using measurement of NK cell activity" was invented by Jae Myun Lee (Seoul, South Korea), Joo Chun Yoon (Seoul, South Korea), Sang Woo Park (Seoul, South Korea) and Jong Sun Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a method for diagnosing cancer, a diagnosis kit and compositions useful for measurement of NK cell activity. The incidence of cancer may be diagnosed by monitoring changes in the in vivo immune system through measurement of NK cell activity in blood. Thus, the incidence...